六、结论与展望
总之,抑郁是PD最常见的并发症之一,可加重患者的运动障碍,严重影响患者的生活质量和疾病预后。目前,对PDD的流行病学特点有一定程度的研究和认识,但是受运动症状和其他非运动症状的影响,诊断较困难,其发病机制的研究还有待进一步完善。关于抑郁的治疗,尚需多中心大样本的病例对照研究,以发现合适的治疗方案。
参考文献
[1]Moussavi S,Chattlerji S,Verdes E,et al.Depression,chronic diseases,and decrements in health:results from the World Health Surveys[J].Lancet,2007,370(95):851-858.
[2]Rayner L,Price A,Evans A,et al.Antidepressants for depression in physically ill people[J].Cochrane Database Syst Rev,2010(3):CD007503.
[3]Slaughter JR,Slaughter KA.Prevalence,clinical manifestations,etiology,and treatment of depression in Parkinson ' s disease[J].J Neuropsychiaty Clin Neurosci,2001,13(2):187-196.
[4]Mitchell AJ,Rao S,Vaze A.Do primary care physicians have particular difficulty identifying late-life depression? A meta-analysis stratified by age[J].Psychother Psychosom,2010,79(5):285-294.
[5]黄世敬,雷小明.老年抑郁症发病机制的研究进展[J].医学综述,2013,19(1):1-4.
[6]张盛宇,李霞.老年抑郁症患病危险因素的研究进展[J].内科理论与实践,2012,7(2):133-136.
[7]杨永秀,潘冰.帕金森病伴抑郁的诊治分析[J].中国康复理论与实践,2009,15(6):545-547.
[8]McDonald WM,Richard IH,DeLong MR.Prevalence,etiology,and treatment of depression in Parkinson's disease[J].Biol Psychiatry,2003,54(3):363-375.
[9]Rihmer Z,Seregi K,Rihmer A.Parkinson's disease and depression[J].Neuropsychopharmacol Hung,2004,6(2):82-85.
[10]Reijnders JS,Ehrt U,Weber WE,et al.A systematic review of prevalence studies of depression in Parkinson's disease[J].Mov Disord 2008,23(2):183-189.
[11]Gage H,Hendricks A,Zhang S,et al.The relative health related quality of life of veterans with Parkinson's disease[J].J Neurol Neurosurg Psychiatry,2003,74(2):163-169.
[12]Ehrt U,Br nnick K,Leentjens AFG,et al.Depressive symptom profile in Parkinson ' s disease:a comparison with depression in elderly patients without Parkinson's disease[J].Int J Geriatr Psychiatry,2006,21(3):252-258.
[13]Funkiewiez A,Ardouin C,Caputo E,et al.Long term effects of bilateral subthalamic nucleus stimulation on cognitive function,mood,and behaviour in Parkinson's disease[J].J Neurol Neurosurg Psychiatry,2004,75:834-839.
[14]陈涛,唐北沙,廖小平.α-突触核蛋白在帕金森病发病机制中的作用[J].中华神经科杂志,2006,39(6):415-418.
[15]梁炜,张红梅,张红云.帕金森病伴发抑郁患者血小板5-羟色胺浓度的对照研究[J].中国实用神经疾病杂志,2009,12(17):50-51.(https://www.daowen.com)
[16]石葛明,樊平,崔慧先,等.帕金森症患者脑标本5-羟色胺转运体的表达[J].基础医学与临床,2007,27(3):263-266.
[17]Remy P,Doder M,Lees A,et al.Depression in Parkinson's disease:loss of dopamine and noradrenaline innervation in the limbic system[J].Brain,2005,128(6):1314-1322.
[18]Nagatsu T,Sawada M.Inflammatory process in Parkinson's disease:role for cytokines[J].Current Pharma Des,2005,11(8):999-1016.
[19]Matsui H,Nishinaka K,Oda M,et al.Depression in Parkinson's disease.Diffusion tensor imaging study[J].J Neurol,2007,254(9):1170-1173.
[20]Cardoso EF,Maia FM,Fregni F,et al.Depression in Parkinson's disease:convergence from voxel - based morphometry and functional magnetic resonance imaging in the limbic thalamus[J].Neuroimage,2009,47(2):467-472.
[21]P lhagen,SE,Ekberg S,W linder J,et al.HMPAO SPECT in Parkinson's disease(PD)with major depression(MD)before and after antidepressant treatment[J].J Neurl,2009,256(9):1510-1518.
[22]Mayberg HS,Starkstein SE,Sadzot B,et al.Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease[J].Ann Neurol,1990,28(1):57-64.
[23]Kalbe E,Calabrese P,Kohn N,et al.Screening for cognitive deficits in Parkinson ' s disease with the Parkinson neuropsychometric dementia assessment(PANDA)instrument[J].Parkinsonism Relat Disord,2008,14(2):93-101.
[24]Inoue T,Kitagawa M,Tanaka T,et al.Depression and major depressive disorder in patients with Parkinson's disease[J].Mov Disord,2010,25(1):44-49.
[25]Williams JR,Hirsch ES,Anderson K,et al.A comparison of nine scales to detect depression in Parkinson disease:which scale to use?[J].Neurology,2012,78(13):998-1006.
[26]Okun MS,Fernandez HH.Will tricyclic antidepressants make a comeback for depressed Parkinson disease patients?[J].Neurology,2009,72(10):868-869.
[27]Menza M,Dobkin RD,Marin H,et al.A controlled trial of antidepressants in patients with Parkinson disease and depression[J].Neurology,2009,72(10):886-892.
[28]Devos D,Dujardin K,Poirot I,et al.Comparison of desipramine and citalopram treatments for depression in Parkinson ' s disease:A double - blind,randomized,placebo-controlled study[J].Mov Disord,2008,23(6):850-857.
[29]Gimenez RS,Dobato JL,Mateo D.Treatment of depression in Parkinson's disease with moclobemide:A pilot open-label study[J].Parkinsonism Relat Disord,1997,3(4):219-225.
[30]Barone P,Poewe W,Albrecht S,et al.Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease:a randomised,doubleblind,placebo-controlled trial[J].Lancet Neurol,2010,9(6):573-580.
(耿德勤)